Acquired angioedema: Clinical Trials

3 trials for Acquired angioedema, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Recruiting 1
Phase 21Completed 1

Follow Acquired angioedema: new trials by email Literature Review of Acquired angioedema trials Research Report on Acquired angioedema

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency
Deucrictibant, Placebo - Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)
Phase 3RecruitingPharvaris Netherlands B.V.482025-10-162026-09-21
C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema
C1 inhibitor concentrate (C1-esteraseremmer-N) - Angioedema
Phase 2 / Phase 3CompletedProthya Biosolutions62006-11-012009-05-04
C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema
C1 inhibitor concentrate (C1-esteraseremmer-N) - Angioedema
Phase 3CompletedProthya Biosolutions152006-02-012009-05-04

Narrower conditions

Angioedema (3)  ·  Hereditary Angioedema Types I and II (2)  ·  Angioedemas, Hereditary (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Hypersensitivity (3)  ·  Hypersensitivity, Immediate (3)  ·  Immune System Diseases (3)  ·  Skin Diseases (3)  ·  Skin Diseases, Vascular (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Urticaria (3)  ·  Vascular Diseases (3)  ·  Angioedemas, Hereditary (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Hereditary Complement Deficiency Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Primary Immunodeficiency Diseases (1)

Sponsors

Prothya Biosolutions (2)  ·  Pharvaris Netherlands B.V. (1)

Countries

Netherlands (3)  ·  Australia (1)  ·  Austria (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  New Zealand (1)  ·  Poland (1)  ·  Spain (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

M. M. Levi, Prof. Dr. (2)